Lepu Biopharma Co., Ltd.

This study tests whether adding two drugs (pucotenlimab and becotatug vedotin) to standard surgery can improve outcomes for people with advanced head and neck cancer that can be removed. About 80 participants will receive the drug combination or a placebo before and after surgery…

This study tests a new drug called MRG004A for people with advanced pancreatic cancer that has not responded to standard treatments. About 231 participants will receive either MRG004A plus best supportive care or a placebo plus best supportive care. The goal is to see if the drug…

This early-stage trial tests a new drug called MRG006A combined with standard immune-boosting and targeted therapies for people with advanced liver cancer that cannot be removed by surgery. The study aims to find the safest dose and check if the combination shrinks tumors. About …